Genflow Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Genflow Biosciences has a total shareholder equity of £858.3K and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.4M and £492.8K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£1.14m |
| Equity | UK£858.35k |
| Total liabilities | UK£492.76k |
| Total assets | UK£1.35m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: WQ5's short term assets (£1.3M) exceed its short term liabilities (£492.8K).
Long Term Liabilities: WQ5 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: WQ5 is debt free.
Reducing Debt: WQ5 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WQ5 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: WQ5 has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 19.5% each year.